Erin L. Volk
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 6
- Cancer-related Molecular Pathways 3
-
- Pharmacological Effects and Toxicity Studies 3
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 2
- Parasitology top 10%
- Nutrition and Dietetics top 10%
-
- Amino Acid Enzymes and Metabolism 2
-
- Cancer Research and Treatments 2
-
- Cancer therapeutics and mechanisms 1
- RNA modifications and cancer 1
- Co-authors
- Erasmus SchneiderJames Chih‐Hsin YangYan WuRobert W. RobeyFei LiE SchneiderAlexey KhodjakovSusan E. Bates
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Infection and Immunity (2 papers)Biochemical Pharmacology (1 paper)
- Partner nations
- United StatesTaiwanDenmark
In The Last Decade
Erin L. Volk
12 papers receiving 913 citations
Peers
Comparison fields: 5 of 77
- Oncology 662
- Pediatrics, Perinatology and Child Health 261
- Infectious Diseases 157
- Parasitology 53
- Nutrition and Dietetics 109
Countries citing papers authored by Erin L. Volk
This map shows the geographic impact of Erin L. Volk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin L. Volk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin L. Volk more than expected).
Fields of papers citing papers by Erin L. Volk
This network shows the impact of papers produced by Erin L. Volk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin L. Volk. The network helps show where Erin L. Volk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erin L. Volk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 15 | |
| 2 | 2008 | 13 | |
| 3 | 2008 | 18 | |
| 4 | Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. | 2003 | 178 |
| 5 | 2003 | 3 | |
| 6 | Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. | 2002 | 207 |
| 7 | Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. | 2001 | 53 |
| 8 | 2000 | 99 | |
| 9 | 2000 | 2 | |
| 10 | 2000 | 145 | |
| 11 | Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. | 2000 | 107 |
| 12 | 2000 | 88 |
About Erin L. Volk
Erin L. Volk is a scholar working on Biochemistry, Biotechnology and Oncology, having authored 12 papers that have together received 928 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer-related Molecular Pathways (3 papers), Amino Acid Enzymes and Metabolism (2 papers), Cancer Research and Treatments (2 papers), HIV/AIDS drug development and treatment (2 papers), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Oncology (662 citations), Pediatrics, Perinatology and Child Health (261 citations) and Infectious Diseases (157 citations). Erin L. Volk has collaborated with scholars based in United States, Taiwan and Denmark. Frequent co-authors include Erasmus Schneider, James Chih‐Hsin Yang, Yan Wu, Robert W. Robey, Fei Li, E Schneider, Alexey Khodjakov, Susan E. Bates, Thomas Litman and Min‐Liang Kuo. Their work appears in journals such as Biochemical and Biophysical Research Communications, Infection and Immunity and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.